Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Placing

6 May 2015 07:01

RNS Number : 2757M
Tekcapital plc
06 May 2015
 

 

6 May 2015

 

Tekcapital plc

("Tekcapital" or "the "Company")

 

Placing to raise £2.15 million

 

The Board of Tekcapital (AIM: TEK), an international provider of technology and intellectual property services, is pleased to announce that the Company has raised gross proceeds of £2.15 million, by way of a placing (the "Placing") of a total of 10,750,000 new ordinary shares of 0.4p each (the "Placing Shares") at a price of 20 pence per share (the "Placing Price"). The Placing, which was conducted by Allenby Capital Limited and Optiva Securities Limited, was oversubscribed.

 

Summary:

 

· Gross proceeds of the Placing amount to a total of £2.15 million, estimated to be £2.02 million net of expenses, excluding VAT.

 

· The net proceeds of the Placing will be used for two purposes:

 

o To expand Tekcapital's sales force to accelerate the growth of its client base for technology transfer and InventionEvaluator services; and

o To enable Tekcapital to acquire and sell-on the licences for additional university intellectual properties.

 

· The Placing Shares will be issued to a range of institutional and other investors, including existing and new shareholders in the Company.

 

· Continuing pipeline of intellectual property licence opportunities for potential acquisition.

 

 

Commenting on the Placing, Dr. Clifford M. Gross, the Company's Chairman, said: "I am very encouraged by the significant level of support that we have received from existing shareholders and also from new investors who have chosen to participate in our growth story. The funds raised will enable us to accelerate our strategy with an expanded sales force driving new client acquisition. We are also continuing to see several extremely interesting technologies in the market place that we believe are suitable for out-licence and have the potential to realise significant value for our shareholders."

 

 

Background to and reasons for the Placing

 

On 14 April 2015, Tekcapital announced that it had acquired the exclusive worldwide licence to a portfolio of 13 optical technology patents from the University of Central Florida. This was the fourth technology licence acquisition transaction that the Company has completed since January 2015 and adds to the previous technology licence acquisitions in the areas of reduced-fat food production (a process called Crackle-BakedTM) and non-invasive glucose measurement for diabetics.

 

Since its admission to AIM, Tekcapital has developed its business and significantly expanded its client base, through the hiring of key sales and marketing executives to drive the adoption of its services. The Company has opened new offices in Miami and Singapore and has signed up new clients in Israel, Finland and the United States.

 

The net proceeds of the Placing will allow Tekcapital to expand its sales force to accelerate the growth of its client base for technology transfer. This will include staff additions in sales, plus advertising and marketing support. In addition, the net proceeds of the Placing will be used to acquire multiple university intellectual property rights for follow on out-licensing or sale.

 

The Placing

 

The Company has raised gross proceeds of £2.15 million (approximately £2.02 million net of estimated expenses before VAT) through the issue of the Placing Shares. The Placing Price represents a discount of approximately 8 per cent. to the closing mid-market price on AIM of Tekcapital's shares of 21.75p on 5 May 2015, being the latest practicable date prior to this announcement. The Placing Shares will represent approximately 31 per cent. of the Company`s enlarged ordinary share capital immediately following Admission (as defined below).

 

Application has been made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM ("Admission"). It is expected that Admission will become effective, and dealings in the Placing Shares will commence, at 8:00 am on 11 May 2015.

 

The Placing Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid in respect of the Company`s ordinary shares of 0.4p each ("Ordinary Shares") after the date of Admission and will otherwise rank pari passu in all respects with the Company`s existing Ordinary Shares.

 

Total Voting Rights

 

The enlarged issued share capital of the Company following the issue of the Placing Shares will be 34,678,539 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in Treasury.

 

Following Admission, the above figure of 34,678,539 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Shareholdings in the Company

 

Following the issue of the Placing Shares, the holdings of the directors of Tekcapital and other shareholders holding in excess of 3 per cent. of the Company's enlarged share capital on Admission are, to the best of the knowledge of the Board of Tekcapital, as follows:

 

Name of Shareholder

Holding of Ordinary Shares

% of enlarged share capital

Clifford M. Gross, Ph.D. (Chairman)

8,657,500

24.97%

Bill Payne (Non-executive Director)

400,000

1.15%

Jeffrey Lewis, J.D. (Non-executive Director)

100,000

0.29%

Carl Nisser, J.D. (Non-executive Director)

100,000

0.29%

Alexander Maxwell Hamilton Inglis

1,525,000

4.40%

RBC Trustees (CI) Limited as trustees of the Priory Accumulation & Maintenance Trust and the Edna Wray Grandchildren's Accumulation & Maintenance Trust (Nigel Wray's family trusts)

6,000,000

17.30%

 

 

 

For further information please contact:

 

Tekcapital plc

+1 305 200 3450 Ext 305

Clifford M. Gross

cgross@tekcapital.com

Allenby Capital Ltd (Nominated Adviser & Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

Optiva Securities Limited (Joint Broker)

+44 (0) 20 3137 1904

Jeremy King / Vishal Balasingham

jeremy.king@optivasecurities.com

FTI Consulting, LLP

+44 (0) 20 3727 1000

Chris Lane / Emma Appleton / Roger Newby

tekcapital@fticonsulting.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

 

Tekcapital helps clients profit from new, university-developed intellectual properties. With our proprietary discovery search engine, linked to 4,000+ universities in 160 countries, coupled with expert scientific review, we provide a turn-key service to make it easy for clients to find and acquire the IP they need to create a competitive advantage. Tekcapital plc is listed on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEUVVWRVAAVRAR
Date   Source Headline
11th Jan 20247:00 amRNSInnovative Eyewear Patent Applications
9th Jan 20247:00 amRNSMicroSalt expand Placement Low Sodium Salt Shakers
22nd Dec 20237:00 amRNSAnnual Corporate & Strategy Update
14th Dec 20237:00 amRNSInnovative Eyewear Appoints Brand Ambassador
13th Dec 20237:00 amRNSInnovative Eyewear Update for Android ChatGPT App
12th Dec 20237:00 amRNSInnovative Eyewear,Inc. Global Licensing Agreement
17th Nov 20237:00 amRNSInnovative Eyewear Launches Upgraded Charging Dock
16th Nov 202312:12 pmRNSForm 8.3 - Belluscura PLC
1st Nov 20237:00 amRNSMicroSalt placement SaltMe! Crisps in MR Williams
19th Oct 20237:00 amRNSMicroSalt placement of SaltMe Low Sodium Crisps
17th Oct 20237:00 amRNSInnovative Eyewear Launches New Collection
16th Oct 20237:00 amRNSTakeover Code Form 8.3 - Belluscura plc
5th Oct 20237:00 amRNSBelluscura Update
5th Oct 20237:00 amRNSNotification of Major Holdings
3rd Oct 20238:00 amRNSMicroSalt Primary Bid Offer Files Schedule One
29th Sep 20238:00 amRNSHalf Yearly Report for period ending 30 June 2023
19th Sep 20237:00 amRNSMicroSalt Partnership with Weijohn Farms Group
13th Sep 20234:15 pmRNSNotification of Major Holdings
11th Sep 20237:00 amRNSInnovative Eyewear Announces Patent Filing
7th Sep 20237:00 amRNSMicroSalt files New Patent to Improve Baked Goods
6th Sep 20237:00 amRNSGuident Update
24th Aug 20237:00 amRNSPortfolio Company Update - Guident
17th Aug 20237:00 amRNSPortfolio Companies Update
14th Aug 20237:00 amRNSLucyd ChatGPT App Update for Smart Eyewear
1st Aug 20237:00 amRNSInnovative Eyewear Launches Lucyd Blueshift Lens
31st Jul 20237:00 amRNSMicroSalt commercial orders for SaltMe Crisps
30th Jun 20237:00 amRNSInnovative Eyewear Miami Fashion Week
28th Jun 20237:00 amRNSInnovative Eyewear Partnership with PRIVATO
26th Jun 20237:00 amRNSMicroSalt Expands U.S. Retail Network
22nd Jun 20231:38 pmRNSResults of Annual General Meeting
22nd Jun 20231:27 pmRNSInnovative Eyewear US$ 4.7Million Public Offering
20th Jun 20237:00 amRNSInnovative Eyewear Licensing Agreement for Reebok
16th Jun 20237:00 amRNSSpace Florida Awards Grant to Guident and NOVELSAT
14th Jun 20237:00 amRNSGuident Secures New Patent
26th May 20237:00 amRNSFinal Results Year ended 31 December 2022
18th May 20237:00 amRNSMicroSalt Jack Stein appointed Brand Ambassador
17th May 20237:00 amRNSMicroSalt expands U.S. retail presence
4th May 20234:40 pmRNSNotification of Major Holdings
2nd May 20237:00 amRNSMicroSalt partners with large USA Retailer
27th Apr 20235:35 pmRNSNotification of Major Holdings
17th Apr 20237:00 amRNSPlacing to raise £2 Million (C.US $ 2.50M)
14th Apr 20238:00 amRNSInnovation Eyewear Hosts First Smart Eyewear Show
12th Apr 20238:00 amRNSPatent Filed for ChatGPT Enabled Smart Eyewear
11th Apr 20238:00 amRNSPortfolio Company Update Innovation Eyewear
22nd Mar 20237:00 amRNSMicroSalt Operational Update
17th Mar 20237:00 amRNSGuident Update
13th Mar 20237:00 amRNSH Mart Partners with MicroSalt
8th Mar 20234:39 pmRNSHolding(s) in Company
8th Mar 20233:59 pmRNSIssue of Equity and total voting rights
2nd Mar 20237:00 amRNSInnovative Eyewear Launches New Titanium Styles

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.